HCV infection and metabolic syndrome: Which is the chicken and which is the egg?

Gastroenterology

Volumn 142, Issue 6, 2012, Pages 1288-1292

  Negro, Francesco ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

HCV; hepatitis C virus; IFN; interferon; LD; lipid droplet; microsomal triglyceride transfer protein; MTTP; very low density lipoprotein; VLDL

Indexed keywords

ADIPONECTIN; ALPHA INTERFERON; CHOLESTEROL; CYTOKINE; DANOPREVIR; INTERLEUKIN 6; LEPTIN; METFORMIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PIOGLITAZONE; RIBAVIRIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADAPTIVE IMMUNITY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FATTY LIVER; GENOTYPE; GLUCOSE METABOLISM; HEPATITIS C; HUMAN; HYPERTENSION; INNATE IMMUNITY; INSULIN RESISTANCE; LIFE CYCLE; LIPID METABOLISM; LIPOGENESIS; LIVER CELL CARCINOMA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NOTE; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; VIRION; VIRUS LOAD; VIRUS REPLICATION;

EID: 84860290546     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.12.063     Document Type: Article

References (25)

1. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
2. D. Lavanchy Evolving epidemiology of hepatitis C virus Clin Microbiol Infect 17 2011 107 115
3. K.G. Alberti, R.H. Eckel, S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
4. S.C. Larsson, A. Wolk Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies Br J Cancer 97 2007 1005 1008
5. A.J. McCullough Epidemiology of the metabolic syndrome in the USA J Dig Dis 12 2011 333 340
6. M. Shaheen, D. Echeverry, M.G. Oblad Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III] Diabetes Res Clin Pract 75 2007 320 326
7. V. Kaddai, F. Negro Current understanding of insulin resistance in hepatitis C Expert Rev Gastroenterol Hepatol 5 2011 503 516
8. E. Bugianesi, F. Salamone, F. Negro The interaction of metabolic factors with HCV infection: does it matter? J Hepatol 56 Suppl 1 2012 S56 S65
9. S. Mirandola, S. Realdon, J. Iqbal Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis Gastroenterology 130 2006 1661 1669
10. G. Waris, D.J. Felmlee, F. Negro Hepatitis C virus induces the proteolytic cleavage of sterol regulatory element binding proteins (SREBPs) and stimulates the phosphorylation of SREBPs via oxidative stress J Virol 81 2007 8122 8130
11. S.B. Kapadia, F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc Natl Acad Sci U S A 102 2005 2561 2566
12. G.H. Syed, Y. Amako, A. Siddiqui Hepatitis C virus hijacks host lipid metabolism Trends Endocrinol Metab 21 2010 33 40
13. Y. Nahmias, J. Goldwasser, M. Casali Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin Hepatology 47 2008 1437 1445
14. S. Clément, C. Fauvelle, S. Pascarella Hepatitis C virus and lipid droplets: role of seipin in lipid droplet maturation and viral life cycle J Hepatol 54 Suppl 1 2011 S311
15. T. Poynard, V. Ratziu, J. McHutchison Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C Hepatology 38 2003 75 85
16. S.H. Mehta, F.L. Brancati, M.S. Sulkowski Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States Ann Intern Med 133 2000 592 599
17. R. Moucari, N. Forestier, D. Larrey Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in genotype 1 chronic hepatitis C patients Gut 59 2010 1694 1698
18. Y. Arase, F. Suzuki, Y. Suzuki Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C Hepatology 49 2009 739 744
19. E. Vanni, M.L. Abate, E. Gentilcore Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C Hepatology 50 2009 697 706
20. S.F. Harrison, M. Hamzeh, E. Lentz Virologic and metabolic responses in chronic hepatitis C (CHC) patients with insulin resistance (IR) treated with pioglitazone and peginterferon alpha-2a plus ribavirin J Hepatol 52 Suppl 1 2010 S129
21. P. Deltenre, A. Louvet, M. Lemoine Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis J Hepatol 55 2011 1187 1194
22. M. Romero-Gómez, M. Diago, R.J. Andrade Treatment of insulin resistance with metformin in nave genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin Hepatology 50 2009 1702 1708
23. F. Caballero, A. Fernndez, A.M. De Lacy Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH J Hepatol 50 2009 789 796
24. G.M. Lord, G. Matarese, J.K. Howard Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394 1998 897 901
25. J.K. Howard, G.M. Lord, G. Matarese Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice J Clin Invest 104 1999 1051 1059